4804 related articles for article (PubMed ID: 27032746)
21. Fertility after contraception or abortion.
Huggins GR; Cullins VE
Fertil Steril; 1990 Oct; 54(4):559-73. PubMed ID: 2209874
[TBL] [Abstract][Full Text] [Related]
22. Pregnancy outcomes after assisted human reproduction.
Okun N; Sierra S; ;
J Obstet Gynaecol Can; 2014 Jan; 36(1):64-83. PubMed ID: 24444289
[TBL] [Abstract][Full Text] [Related]
23. The prevention of early-onset neonatal group B streptococcal disease.
Money D; Allen VM;
J Obstet Gynaecol Can; 2013 Oct; 35(10):939-948. PubMed ID: 24165063
[TBL] [Abstract][Full Text] [Related]
24. [Contraception and pelvic infection in women].
Keith L; Berger GS; Brown ER
Contracept Fertil Sex (Paris); 1986 Jan; 14(1):49-58. PubMed ID: 12341241
[TBL] [Abstract][Full Text] [Related]
25. What proportion of Canadian women will accept an intrauterine contraceptive at the time of second trimester abortion? Baseline data from a randomized controlled trial.
Norman WV; Brooks M; Brant R; Soon JA; Majdzadeh A; Kaczorowski J
J Obstet Gynaecol Can; 2014 Jan; 36(1):51-59. PubMed ID: 24444287
[TBL] [Abstract][Full Text] [Related]
26. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
Luukkainen T; Toivonen J
Contraception; 1995 Nov; 52(5):269-76. PubMed ID: 8585882
[TBL] [Abstract][Full Text] [Related]
27. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.
Chi IC
Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615
[TBL] [Abstract][Full Text] [Related]
28. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
Modesto W; Bahamondes MV; Bahamondes L
Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309
[TBL] [Abstract][Full Text] [Related]
29. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
[TBL] [Abstract][Full Text] [Related]
30. New IPPF statement on breastfeeding, fertility and post-partum contraception.
International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
IPPF Med Bull; 1990 Apr; 24(2):2-4. PubMed ID: 12316285
[TBL] [Abstract][Full Text] [Related]
31. Long-acting reversible contraception immediately after medical abortion: systematic review with meta-analyses.
Schmidt-Hansen M; Hawkins JE; Lord J; Williams K; Lohr PA; Hasler E; Cameron S
Hum Reprod Update; 2020 Feb; 26(2):141-160. PubMed ID: 32096862
[TBL] [Abstract][Full Text] [Related]
32. Hormonal intrauterine devices.
Rybo G; Andersson K; Odlind V
Ann Med; 1993 Apr; 25(2):143-7. PubMed ID: 8489751
[TBL] [Abstract][Full Text] [Related]
33. Immediate postpartum intrauterine device and implant program outcomes: a prospective analysis.
Eggebroten JL; Sanders JN; Turok DK
Am J Obstet Gynecol; 2017 Jul; 217(1):51.e1-51.e7. PubMed ID: 28342716
[TBL] [Abstract][Full Text] [Related]
34. Advanced reproductive age and fertility.
Liu K; Case A;
J Obstet Gynaecol Can; 2011 Nov; 33(11):1165-1175. PubMed ID: 22082792
[TBL] [Abstract][Full Text] [Related]
35. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Lethaby AE; Cooke I; Rees M
Cochrane Database Syst Rev; 2005 Oct; (4):CD002126. PubMed ID: 16235297
[TBL] [Abstract][Full Text] [Related]
36. SOGC clinical practice guideline. No. 252, December 2010. Oral contraceptives and the risk of venous thromboembolism: an update.
Reid R;
J Obstet Gynaecol Can; 2010 Dec; 32(12):1192-1197. PubMed ID: 21176332
[TBL] [Abstract][Full Text] [Related]
37. Postpartum options: matching the method to individual needs.
Townsend S
Netw Res Triangle Park N C; 1990 Aug; 11(3):12-5. PubMed ID: 12342904
[TBL] [Abstract][Full Text] [Related]
38. Alcohol use and pregnancy consensus clinical guidelines.
Carson G; Cox LV; Crane J; Croteau P; Graves L; Kluka S; Koren G; Martel MJ; Midmer D; Nulman I; Poole N; Senikas V; Wood R;
J Obstet Gynaecol Can; 2010 Aug; 32(8 Suppl 3):S1-31. PubMed ID: 21172102
[TBL] [Abstract][Full Text] [Related]
39. Post coital contraception.
Haspels AA; Van Santen MR
J Gynaecol Endocrinol; 1986; 2(1-2):17-24. PubMed ID: 12269214
[TBL] [Abstract][Full Text] [Related]
40. Substance use in pregnancy.
Wong S; Ordean A; Kahan M; ; ; ; ;
J Obstet Gynaecol Can; 2011 Apr; 33(4):367-384. PubMed ID: 21501542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
